NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Webb NJA, Woolley RL, Lambe T, et al. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT. Southampton (UK): NIHR Journals Library; 2019 May. (Health Technology Assessment, No. 23.26.)
Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
Show detailsTABLE 21
Score | Group | Mean difference (95% CI) | p-value | |
---|---|---|---|---|
SC | EC | |||
t-score | ||||
4 weeks | ||||
n | 104 | 109 | ||
Mean (SD) | 53.28 (12.37) | 52.36 (12.36) | –0.92 (–4.26 to 2.42) | 0.6 |
16 weeks | ||||
n | 97 | 104 | ||
Mean (SD) | 51.47 (13.10) | 50.21 (13.91) | –1.26 (–5.03 to 2.50) | 0.5 |
12 months | ||||
n | 98 | 102 | ||
Mean (SD) | 50.84 (15.52) | 49.31 (13.31) | –1.52 (–5.55 to 2.50) | 0.5 |
24 months | ||||
n | 92 | 94 | ||
Mean (SD) | 48.95 (13.81) | 49.36 (13.54) | 0.42 (–3.54 to 4.37) | 0.8 |
36 months | ||||
n | 61 | 61 | ||
Mean (SD) | 49.07 (13.50) | 48.87 (13.74) | –0.20 (–5.08 to 4.69) | 0.9 |
48 months | ||||
n | 32 | 28 | ||
Mean (SD) | 50.13 (15.18) | 46.61 (13.06) | –3.52 (–10.89 to 3.86) | 0.3 |
Total | ||||
4 weeks | ||||
n | 105 | 111 | ||
Mean (SD) | 37.28 (26.83) | 35.32 (25.86) | –1.96 (–9.03 to 5.11) | 0.6 |
16 weeks | ||||
n | 97 | 105 | ||
Mean (SD) | 34.30 (27.37) | 31.20 (27.10) | –3.10 (–10.66 to 4.46) | 0.4 |
12 months | ||||
n | 98 | 102 | ||
Mean (SD) | 34.34 (31.67) | 29.22 (24.88) | –5.12 (–13.09 to 2.85) | 0.2 |
24 months | ||||
n | 93 | 95 | ||
Mean (SD) | 28.92 (26.37) | 28.08 (25.15) | –0.84 (–8.25 to 6.57) | 0.8 |
36 months | ||||
n | 61 | 61 | ||
Mean (SD) | 27.11 (25.11) | 26.90 (26.15) | –0.21 (–9.40 to 8.98) | 1.0 |
48 months | ||||
n | 32 | 28 | ||
Mean (SD) | 29.56 (27.77) | 21.25 (21.06) | –8.31 (–21.20 to 4.57) | 0.2 |
A higher score is worse. A negative difference favours the EC group.
TABLE 22
Score | Group | RRa (95% CI) | p-value | |
---|---|---|---|---|
SC | EC | |||
Normal/abnormal scores | ||||
4 weeks | ||||
n | 104 | 109 | ||
Normal score (%) | 72 (69) | 79 (72) | ||
16 weeks | ||||
n | 97 | 104 | ||
Normal score (%) | 71 (73) | 77 (74) | 0.98 (0.86 to 1.10) | 0.9 |
12 months | ||||
n | 98 | 102 | ||
Normal score (%) | 69 (70) | 78 (76) | 0.97 (0.84 to 1.12) | 0.3 |
24 months | ||||
n | 92 | 94 | ||
Normal score (%) | 72 (78) | 70 (74) | 1.06 (0.92 to 1.23) | 0.8 |
36 months | ||||
n | 61 | 61 | ||
Normal score (%) | 47 (77) | 47 (77) | 0.98 (0.83 to 1.14) | 1.0 |
48 months | ||||
n | 32 | 28 | ||
Normal score (%) | 22 (69) | 22 (79) | 0.99 (0.73 to 1.35) | 0.4 |
ACBC t-scores are categorised as normal < 60 or abnormal ≥ 60.
- a
Adjusting for 4-week ‘normal score’ status.
- Achenbach Child Behaviour Checklist - Sixteen-week versus standard eight-week pr...Achenbach Child Behaviour Checklist - Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT
- Additional meta-analysis results - Coenzyme Q10 to manage chronic heart failure ...Additional meta-analysis results - Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation
- Acknowledgements - Carer administration of as-needed subcutaneous medication for...Acknowledgements - Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT
- Methods for the descriptive analysis and systematic review of effectiveness - Ad...Methods for the descriptive analysis and systematic review of effectiveness - Adaptive E-Learning to Improve Dietary Behaviour: A Systematic Review and Cost-Effectiveness Analysis
- Background - Adaptive E-Learning to Improve Dietary Behaviour: A Systematic Revi...Background - Adaptive E-Learning to Improve Dietary Behaviour: A Systematic Review and Cost-Effectiveness Analysis
Your browsing activity is empty.
Activity recording is turned off.
See more...